| Round 1 Grantees |
| Westside Health Services, Inc., New York |
| University of Southern California, California |
| University of California-Irvine, California |
| Yale University School of Medicine, Connecticut |
| Olive View-UCLA -DREW, California |
| Neighborhood Health Plan of Rhode Island, Rhode Island |
| Choctaw Nation Health Services Authority, Oklahoma |
| Cooper Green Hospital, Alabama |
| Morehouse School of Medicine, Georgia |
| Massachusetts League of Community Health Centers, Massachusetts |
| Harvard Vanguard Medical Associates, Massachusetts |
| Round 2 Grantees |
|
Harvard Vanguard Medical Associates, Massachusetts
The Expanded Chronic Care Model: Targeting Disparities in Diabetes Care
From left to right—John Ayanian, Dana Gelb Safran, Richard Marshall, Thomas Sequist, Amy Marston
Many large health care systems are adopting components of the Chronic Care Model (CCM) to achieve substantial gains in diabetes care. Harvard Vanguard Medical Associates (HVMA) is a large, integrated health care delivery system in eastern Massachusetts that has implemented the CCM. This project will use a randomized, controlled study design within HVMA to evaluate whether enhancements to the CCM can produce significant improvement in the quality of diabetes care for Black patients. Intervention clinicians will receive bimonthly panel-level disparities report cards, health navigation training, and cultural competency training. The study will occur over a 12 month period and involve 4,000 White patients and 2,500 Black patients with diabetes who are receiving care at 8 health centers. The primary outcomes will include rates of glucose (HbA1c <7.0), LDL cholesterol (<100 mg/dL), and blood pressure (<130/80) control. Using patient focus groups, this program will identify significant barriers to care and guide health navigation training. Clinicians will be surveyed pre- and post-intervention to assess the effect of the intervention on knowledge and attitudes towards health disparities. Patient experiences will be assessed pre- and post-intervention using a validated instrument to determine whether the intervention can reduce existing racial disparities in patient reports of quality. HVMA will perform a cost analysis related to the intervention using a health system perspective.
Website:
http://www.harvardvanguard.org
Contact:
Thomas D. Sequist, MD, MPH (tsequist@partners.org)
Principal Investigator:
Thomas D. Sequist, MD, MPH
Team Members:
John Z. Ayanian, MD, MPP, Co-Investigator
Dana Gelb Safran, ScD, Co-Investigator
Richard Marshall, MD, Co-Investigator
Amy Marston, Project Manager
|
